As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Genesis IBRC India Limited approved unaudited financial results for Q3 FY26 and the nine months ended December 31, 2025. The company reported zero income from operations during the period, with total expenses of ₹3.18 lakhs in Q3 and ₹21.46 lakhs in the nine-month period. This resulted in a net loss of ₹3.18 lakhs for the quarter and ₹21.46 lakhs for the nine months, compared to a profit of ₹352.70 lakhs in the corresponding nine-month period of FY25 (which came entirely from other income, not operations). The auditor, M.N. Rao & Associates LLP, issued a clean limited review report with no qualifications. The company's other equity stands at negative ₹446.74 lakhs as of March 31, 2025, indicating accumulated losses exceeding capital.
Shareholders should note the company has generated no operating revenue, is posting losses, and has negative reserves. The stock is likely to be viewed negatively given the complete absence of business income and deteriorating financial position.